Achromobacter xylosoxidans Pneumonia in a Young Child with Chronic Granulomatous Disease—a Case-Based Review

[1]  O. Ohara,et al.  Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India , 2021, Frontiers in Immunology.

[2]  K. Jahnz-Różyk,et al.  From infections to autoimmunity: Diagnostic challenges in common variable immunodeficiency , 2020, World journal of clinical cases.

[3]  M. Janarthanan,et al.  Achromobacter xylosoxidans Sepsis Unveiling X-linked Agammaglobulinemia Masquerading as Systemic-onset Juvenile Idiopathic Arthritis , 2019, Indian Pediatrics.

[4]  Janet S. Lee,et al.  Successful Lung Transplantation in a Patient with Chronic Granulomatous Disease , 2019, Journal of Clinical Immunology.

[5]  H. Suchanek,et al.  The first Polish cohort of adult patients with common variable immunodeficiency from 4 specialized centers: do we provide standards of care? , 2018, Polish archives of internal medicine.

[6]  Kevin E. Shopsowitz,et al.  The importance of functional validation after next‐generation sequencing: evaluation of a novel CARD11 variant , 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[7]  S. Holland,et al.  MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections. , 2017, JCI insight.

[8]  Cebrayil Cebrayilov,et al.  Hepatic Granuloma Mimicking Tuberculosis: Achromobacter Xylosoxidans in a Patient with Familial Mediterranean Fever , 2017 .

[9]  Amitabh Singh,et al.  Achromobacter xylosoxidans Septic Arthritis in a Child with Primary Immunodeficiency , 2017, Journal of global infectious diseases.

[10]  A. Kowalczyk,et al.  Achromobacter xylosoxidans as a new microorganism strain colonizing high-density polyethylene as a key step to its biodegradation , 2016, Environmental Science and Pollution Research.

[11]  A. Schäffer,et al.  The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. , 2015, The Journal of allergy and clinical immunology.

[12]  S. Duraisingham,et al.  Immune deficiency: changing spectrum of pathogens , 2015, Clinical and experimental immunology.

[13]  J. Wedzicha,et al.  Editorial Changes and Opportunities at the AJRCCM , 2015 .

[14]  S. Nejentsev,et al.  Immunodeficiency and disseminated mycobacterial infection associated with homozygous nonsense mutation of IKKβ☆ , 2014, The Journal of allergy and clinical immunology.

[15]  E. McGrath,et al.  A Teenager Patient With Recurrent Pulmonary Abscesses. , 2014, Journal of the Pediatric Infectious Diseases Society.

[16]  D. Richman,et al.  Antibody Response to Achromobacter xylosoxidans during HIV Infection Is Associated with Lower CD4 Levels and Increased Lymphocyte Activation , 2013, Clinical and Vaccine Immunology.

[17]  David T. Miller,et al.  Novel presentation of Omenn syndrome in association with aniridia. , 2008, The Journal of allergy and clinical immunology.

[18]  M. Monteduro,et al.  A case of chronic otitis caused by Achromobacter xylosoxidans in children with severe combined immunodeficiency (SCID) , 2009 .

[19]  M. Vaneechoutte,et al.  Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[20]  A. Freeman,et al.  Chronic granulomatous disease presenting with eosinophilic inflammation. , 2005, The Pediatric infectious disease journal.

[21]  P. Peña,et al.  Achromobacter xylosoxidans Bacteremia: A 10-Year Analysis of 54 Cases , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  D. Haas,et al.  Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  H. Ochs,et al.  A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. , 1994, The Journal of clinical investigation.

[24]  E. Anaissie,et al.  Bacteremia due to Achromobacter xylosoxidans in patients with cancer. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Fuhrer,et al.  Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature , 1988, Journal of clinical microbiology.

[26]  C. Cobbs,et al.  Clinical and laboratory characteristics of Achromobacter xylosoxidans infection , 1980, Journal of clinical microbiology.

[27]  G. Hodges,et al.  Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency. , 1978, American journal of clinical pathology.